Contreras Jaime

CIK 00015870701 companyABBOTT PARK, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001587070

Recent Transactions

50 trades

Exercise/Conversion
ABBOTT LABORATORIES$ABT
Common shares without par value
2020-04-21$59.94/sh+36,715→ 119,750 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Common shares without par value
2020-04-21$75.90/sh+25,681→ 145,431 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Option (right to buy)
2020-04-21−36,715→ 36,715 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Common shares without par value
2020-04-21$44.40/sh+46,016→ 83,035 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Option (right to buy)
2020-04-21−46,016→ 0 total
Tax Payment
ABBOTT LABORATORIES$ABT
Common shares without par value
2020-04-21$98.00/sh−83,226→ 62,205 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Option (right to buy)
2020-04-21−25,681→ 51,364 total
Tax Payment
ABBOTT LABORATORIES$ABT
Common shares without par value
2020-03-31$79.34/sh−343→ 2,624 total
Award
ABBOTT LABORATORIES$ABT
Common shares without par value
2020-03-31+740→ 2,967 total
Sale
ABBOTT LABORATORIES$ABT
Common shares without par value
2020-03-02$77.89/sh−2,001→ 37,019 total
Tax Payment
ABBOTT LABORATORIES$ABT
Common shares without par value
2020-02-28$79.19/sh−6,936→ 39,020 total
Award
ABBOTT LABORATORIES$ABT
Common shares without par value
2020-02-21+11,250→ 45,956 total
Award
ABBOTT LABORATORIES$ABT
Option (right to buy)
2020-02-21+68,578→ 68,578 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Option (right to buy)
2019-04-26−80,860→ 0 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-04-26$38.40/sh+80,860→ 115,566 total
Tax Payment
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-04-26$78.11/sh−57,962→ 57,604 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-04-25$59.94/sh+36,716→ 117,438 total
Sale
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-04-25$70.02/sh−12,332→ 34,706 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Option (right to buy)
2019-04-25−36,716→ 73,430 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Option (right to buy)
2019-04-25−46,016→ 46,016 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-04-25$44.40/sh+46,016→ 80,722 total
Sale
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-04-25$70.00/sh−70,400→ 47,038 total
Sale
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-04-22$73.12/sh−918→ 2,227 total
Tax Payment
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-03-31$79.94/sh−385→ 3,145 total
Award
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-03-31+935→ 3,530 total
Sale
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-03-01$78.28/sh−600→ 112,574 total
Sale
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-03-01$78.29/sh−1,333→ 113,174 total
Sale
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-03-01$78.29/sh−300→ 114,507 total
Sale
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-03-01$78.30/sh−600→ 114,807 total
Sale
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-03-01$78.30/sh−100→ 115,407 total
Sale
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-03-01$78.31/sh−200→ 115,807 total
Sale
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-03-01$78.30/sh−300→ 115,507 total
Sale
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-03-01$78.28/sh−402→ 112,172 total
Sale
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-03-01$78.28/sh−8,726→ 103,446 total
Tax Payment
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-02-28$77.23/sh−9,992→ 116,007 total
Award
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-02-22+14,698→ 125,999 total
Award
ABBOTT LABORATORIES$ABT
Option (right to buy)
2019-02-22+77,045→ 77,045 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Option (right to buy)
2019-01-31−77,550→ 80,860 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-01-31$47.00/sh+62,600→ 154,248 total
Tax Payment
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-01-31$71.68/sh−108,090→ 111,301 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-01-31$38.40/sh+77,550→ 231,798 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Option (right to buy)
2019-01-31−62,600→ 0 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Option (right to buy)
2019-01-30−83,951→ 62,600 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-01-30$47.00/sh+83,951→ 269,105 total
Sale
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-01-30$70.00/sh−177,457→ 91,648 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Option (right to buy)
2019-01-30−46,017→ 92,032 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-01-30$38.40/sh+84,169→ 185,154 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Common shares without par value
2019-01-30$44.40/sh+46,017→ 100,985 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Option (right to buy)
2019-01-30−84,169→ 158,410 total
Exercise/Conversion
ABBOTT LABORATORIES$ABT
Common shares without par value
2018-08-29$34.94/sh+59,800→ 110,236 total

Companies

ABBOTT LABORATORIES
Senior Vice President
$ABT

Recent Filings

Address

100 ABBOTT PARK ROAD

ABBOTT PARK, IL, 60064

View on SEC.gov